{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:18:10Z","timestamp":1772173090154,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":39,"publisher":"Springer US","isbn-type":[{"value":"9781071621271","type":"print"},{"value":"9781071621288","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2128-8_22","type":"book-chapter","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T10:03:21Z","timestamp":1645783401000},"page":"279-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Analysis of the Sphingolipidome in NAFLD"],"prefix":"10.1007","author":[{"given":"David","family":"Montefusco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johana","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Allegood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Ashley","family":"Cowart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ajhg.2010.09.010","volume":"87","author":"A Rotthier","year":"2010","unstructured":"Rotthier A, Auer-Grumbach M, Janssens K et al (2010) Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am J Hum Genet 87:513\u2013522","journal-title":"Am J Hum Genet"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00592-020-01612-7","volume":"58","author":"J Weyler","year":"2021","unstructured":"Weyler J, Verrijken A, Hornemann T et al (2021) Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease. Acta Diabetol 58:319\u2013327","journal-title":"Acta Diabetol"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"37275","DOI":"10.1074\/jbc.M608066200","volume":"281","author":"T Hornemann","year":"2006","unstructured":"Hornemann T, Richard S, Rutti MF et al (2006) Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase. J Biol Chem 281:37275\u201337281","journal-title":"J Biol Chem"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1042\/BJ20070025","volume":"405","author":"T Hornemann","year":"2007","unstructured":"Hornemann T, Wei Y, von Eckardstein A (2007) Is the mammalian serine palmitoyltransferase a high-molecular-mass complex? Biochem J 405:157\u2013164","journal-title":"Biochem J"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"15591","DOI":"10.1073\/pnas.2002391117","volume":"117","author":"MA Lone","year":"2020","unstructured":"Lone MA, H\u00fclsmeier AJ, Saied EM et al (2020) Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases. Proc Natl Acad Sci U S A 117:15591\u201315598","journal-title":"Proc Natl Acad Sci U S A"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"26322","DOI":"10.1074\/jbc.M109.023192","volume":"284","author":"T Hornemann","year":"2009","unstructured":"Hornemann T, Penno A, Rutti MF et al (2009) The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J Biol Chem 284:26322\u201326330","journal-title":"J Biol Chem"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","volume":"688","author":"CR Gault","year":"2010","unstructured":"Gault CR, Obeid LM, Hannun YA (2010) An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med Biol 688:1\u201323","journal-title":"Adv Exp Med Biol"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.bbalip.2014.09.009","volume":"1841","author":"WJ Park","year":"2014","unstructured":"Park WJ, Park JW, Merrill AH et al (2014) Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length. Biochim Biophys Acta Mol Cell Biol Lipids 1841:1754\u20131766","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","volume":"20","author":"S Raichur","year":"2014","unstructured":"Raichur S, Wang ST, Chan PW et al (2014) CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab 20:687\u2013695","journal-title":"Cell Metab"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.bbrc.2018.05.078","volume":"504","author":"DJ Montefusco","year":"2018","unstructured":"Montefusco DJ, Allegood JC, Spiegel S et al (2018) Non-alcoholic fatty liver disease: insights from sphingolipidomics. Biochem Biophys Res Commun 504:608\u2013616","journal-title":"Biochem Biophys Res Commun"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.12997\/jla.2020.9.1.50","volume":"9","author":"SA Summers","year":"2020","unstructured":"Summers SA (2020) Ceramides: nutrient signals that drive hepatosteatosis. J Lipid Atheroscler 9:50\u201365","journal-title":"J Lipid Atheroscler"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"16568","DOI":"10.1074\/jbc.273.26.16568","volume":"273","author":"H Zhou","year":"1998","unstructured":"Zhou H, Summers SA, Birnbaum MJ et al (1998) Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 273:16568\u201316575","journal-title":"J Biol Chem"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1128\/MCB.18.9.5457","volume":"18","author":"SA Summers","year":"1998","unstructured":"Summers SA, Garza LA, Zhou H et al (1998) Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18:5457\u20135464","journal-title":"Mol Cell Biol"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.abb.2003.08.020","volume":"419","author":"JA Chavez","year":"2003","unstructured":"Chavez JA, Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419:101\u2013109","journal-title":"Arch Biochem Biophys"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","volume":"22","author":"JY Xia","year":"2015","unstructured":"Xia JY, Holland WL, Kusminski CM et al (2015) Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis. Cell Metab 22:266\u2013278","journal-title":"Cell Metab"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","volume":"20","author":"SM Turpin","year":"2014","unstructured":"Turpin SM, Nicholls HT, Willmes DM et al (2014) Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 20:678\u2013686","journal-title":"Cell Metab"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.bbrc.2017.10.110","volume":"494","author":"AY Lee","year":"2017","unstructured":"Lee AY, Lee JW, Kim JE et al (2017) Dihydroceramide is a key metabolite that regulates autophagy and promotes fibrosis in hepatic steatosis model. Biochem Biophys Res Commun 494:460\u2013469","journal-title":"Biochem Biophys Res Commun"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","volume":"32","author":"Y Guri","year":"2017","unstructured":"Guri Y, Colombi M, Dazert E et al (2017) mTORC2 promotes tumorigenesis via lipid synthesis. Cancer Cell 32:807\u2013823.e12","journal-title":"Cancer Cell"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2337\/dc17-1318","volume":"41","author":"M Apostolopoulou","year":"2018","unstructured":"Apostolopoulou M, Gordillo R, Koliaki C et al (2018) Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steato hepatitis. Diabetes Care 41:1235\u20131243","journal-title":"Diabetes Care"},{"issue":"1","key":"22_CR20","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1038\/s41598-020-66458-z","volume":"10","author":"DP Kumar","year":"2020","unstructured":"Kumar DP, Caffrey R, Marioneaux J et al (2020) The PPAR \u03b1\/\u03b3 agonist saroglitazar improves insulin resistance and steatohepatitis in a diet induced animal model of nonalcoholic fatty liver disease. Sci Rep 10(1):9330","journal-title":"Sci Rep"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.bcp.2013.10.005","volume":"86","author":"X Wang","year":"2013","unstructured":"Wang X, Zhang DM, Gu TT et al (2013) Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1\/sphingosine 1-phosphate signaling pathway. Biochem Pharmacol 86:1791\u20131804","journal-title":"Biochem Pharmacol"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.3389\/fimmu.2018.02980","volume":"9","author":"CY Liao","year":"2018","unstructured":"Liao CY, Song MJ, Gao Y et al (2018) Hepatocyte-derived lipotoxic extracellular vesicle sphingosine 1-phosphate induces macrophage chemotaxis. Front Immunol 9:2980","journal-title":"Front Immunol"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"G300","DOI":"10.1152\/ajpgi.00222.2016","volume":"312","author":"AS Mauer","year":"2017","unstructured":"Mauer AS, Hirsova P, Maiers JL et al (2017) Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 312:G300\u2013G313","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1194\/jlr.M063511","volume":"56","author":"T Geng","year":"2015","unstructured":"Geng T, Sutter A, Harland MD et al (2015) SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes. J Lipid Res 56:2359\u20132371","journal-title":"J Lipid Res"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1194\/jlr.M093799","volume":"60","author":"TD Rohrbach","year":"2019","unstructured":"Rohrbach TD, Asgharpour A, Maczis MA et al (2019) FTY720\/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. J Lipid Res 60:1311\u20131322","journal-title":"J Lipid Res"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3389\/fimmu.2019.01706","volume":"10","author":"A Weigert","year":"2019","unstructured":"Weigert A, Olesch C, Br\u00fcne B (2019) Sphingosine-1-phosphate and macrophage biology-how the sphinx tames the big eater. Front Immunol 10:1706","journal-title":"Front Immunol"},{"issue":"1","key":"22_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41419-019-2214-9","volume":"11","author":"K Wang","year":"2020","unstructured":"Wang K, Li C, Lin X et al (2020) Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress. Cell Death Dis 11(1):28","journal-title":"Cell Death Dis"},{"key":"22_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.627424","volume":"11","author":"AN Srinivas","year":"2021","unstructured":"Srinivas AN, Suresh D, Santhekadur PK et al (2021) Extracellular vesicles as inflammatory drivers in NAFLD. Front Immunol 11:627424","journal-title":"Front Immunol"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1053\/j.gastro.2020.06.031","volume":"159","author":"D Dasgupta","year":"2020","unstructured":"Dasgupta D, Nakao Y, Mauer AS et al (2020) IRE1A stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis. Gastroenterology 159:1487\u20131503.e17","journal-title":"Gastroenterology"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1194\/jlr.M063412","volume":"57","author":"E Kakazu","year":"2016","unstructured":"Kakazu E, Mauer AS, Yin M et al (2016) Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1 \u03b1-dependent manner. J Lipid Res 57:233\u2013245","journal-title":"J Lipid Res"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.livres.2018.01.001","volume":"2","author":"A Eguchi","year":"2018","unstructured":"Eguchi A, Feldstein AE (2018) Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases. Liver Res 2:30\u201334","journal-title":"Liver Res"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3389\/fendo.2019.00665","volume":"10","author":"M Jiang","year":"2019","unstructured":"Jiang M, Li C, Liu Q et al (2019) Inhibiting ceramide synthesis attenuates hepatic steatosis and fibrosis in rats with non-alcoholic fatty liver disease. Front Endocrinol 10:665","journal-title":"Front Endocrinol"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2353\/ajpath.2010.091257","volume":"177","author":"A Moles","year":"2010","unstructured":"Moles A, Tarrats N, Morales A et al (2010) Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis. Am J Pathol 177:1214\u20131224","journal-title":"Am J Pathol"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jhep.2014.06.009","volume":"61","author":"R Fucho","year":"2014","unstructured":"Fucho R, Mart\u00ednez L, Baulies A et al (2014) ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis. J Hepatol 61:1126\u20131134","journal-title":"J Hepatol"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbalip.2012.07.022","volume":"1831","author":"S Schwalm","year":"2013","unstructured":"Schwalm S, Pfeilschifter J, Huwiler A (2013) Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases. Biochim Biophys Acta 1831:239\u2013250","journal-title":"Biochim Biophys Acta"},{"key":"22_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1021\/cb5008426","volume":"10","author":"WL Santos","year":"2015","unstructured":"Santos WL, Lynch KR (2015) Drugging sphingosine kinases. ACS Chem Biol 10:225\u2013233","journal-title":"ACS Chem Biol"},{"key":"22_CR37","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/art.27463","volume":"62","author":"S Bu","year":"2010","unstructured":"Bu S, Asano Y, Bujor A et al (2010) Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels. Arthritis Rheum 62:2117\u20132126","journal-title":"Arthritis Rheum"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"19593","DOI":"10.1074\/jbc.M802417200","volume":"283","author":"S Bu","year":"2008","unstructured":"Bu S, Kapanadze B, Hsu T et al (2008) Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-\u03b2\/Smad signaling are mediated through the PTEN\/PPM1A-dependent pathway. J Biol Chem 283:19593\u201319602","journal-title":"J Biol Chem"},{"key":"22_CR39","doi-asserted-by":"crossref","unstructured":"Engstler AJ, Sellmann C, Jin CJ et al (2017) Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: role of intestinal barrier function. Mol Nutr Food Res 61","DOI":"10.1002\/mnfr.201600985"}],"container-title":["Methods in Molecular Biology","Non-Alcoholic Steatohepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2128-8_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T02:38:35Z","timestamp":1700275115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2128-8_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071621271","9781071621288"],"references-count":39,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2128-8_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"25 February 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}